Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) — Aclarion, […]
ConnectOne Bancorp, Inc. to Host 2024 Third Quarter Results Conference Call on October 24, 2024
ENGLEWOOD CLIFFS, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company […]
Wabash Partners with University of Delaware to Advance Solar Solutions in Commercial Transportation
LAFAYETTE, Ind., Oct. 10, 2024 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, […]
Reliance, Inc. to Announce Third Quarter 2024 Results on Thursday, October 24th
SCOTTSDALE, Ariz., Oct. 10, 2024 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE:RS) announced today that it will report third quarter 2024 […]
TSX News -
Descartes’ Study Reveals Nearly 90% of Consumers’ Sustainable Home Delivery Choices Are Impacted by Economic Pressure
ATLANTA and LONDON, Oct. 10, 2024 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive […]
Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024
VANCOUVER, British Columbia, Oct. 10, 2024 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse […]
TSX News -
Orezone Intersects 1.64 g/t Gold Over 46.00m Significantly Extending Mineralization 240m Below Life of Mine Reserve Pit
VANCOUVER, British Columbia, Oct. 10, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) […]
Azimut and SOQUEM Uncover Extensive Lithium Targets on the Galinée Property, James Bay region, Quebec
LONGUEUIL, Quebec, Oct. 10, 2024 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to […]
GSI Technology to Announce Fiscal Second Quarter 2025 Results on October 24, 2024
SUNNYVALE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), developer of the Gemini® Associative Processing Unit […]
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced […]
